ReneeDarnell ElithWrightMD

PubMed

• 81 citations
  Inhibition of USP10 induces degradation of oncogenic FLT3
  Ellen Weisberg, Nathan J. Schauer, Jing Yang, Ilaria Lamberto, Laura M. Doherty, Shruti Bhatt, Atsushi Nonami, Chengcheng Meng, Anthony Letai, Renee Wright, Hong L. Ti...> ;Nature Chemical Biology. 2017 Oct 2
• 5 citations
  A case-based teaching module combined with audit and feedback to improve the quality of consultations.
  Renee Wright, Eric E. Howell, Regina Landis, Scott M. Wright, Flora Kisuule, Myechia Minter Jordan> ;Journal of Hospital Medicine. 2009 Oct 1
• 335 citations
  CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
  Abdel Kareem Azab, Judith Runnels, Costas Pitsillides, Anne-Sophie Moreau, Feda Azab, Xavier Leleu, Xiaoying Jia, Renee Wright, Beatriz Ospina, Alicia L. Carlson, Clem...> ;Blood. 2009 Apr 30
• 254 citations
  HOXA9 is required for survival in human MLL-rearranged acute leukemias
  Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs, Renee Wright, Tina N. Davis, Marry M. van den Heuvel-Eibrink, Christian M. Zwaan, Andrew L. Kung, Scott A. Armstrong> ;Blood. 2009 Mar 12
• Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells.
  Weisberg, E., Roesel, J., Bold, G., Furet, P., Jiang, J., Cools, J., Wright, R.D., Nelson, E., Barrett, R., Ray, A., Moreno, D., Hall-Meyers, E., Stone, R., Galinsky, ...> ;Blood. 2008-12-15
• Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins.
  Ziegler, D.S., Wright, R.D., Kesari, S., Lemieux, M.E., Tran, M.A., Jain, M., Zawel, L., Kung, A.L.> ;J Clin Invest. 2008 Sep
• Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.
  Hahn, C.K., Ross, K.N., Warrington, I.M., Mazitschek, R., Kanegai, C.M., Wright, R.D., Kung, A.L., Golub, T.R., Stegmaier, K.> ;Proc Natl Acad Sci U S A. 2008 Jul 15
• Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
  Weisberg, E., Wright, R.D., McMillin, D.W., Mitsiades, C., Ray, A., Barrett, R., Adamia, S., Stone, R., Galinsky, I., Kung, A.L., Griffin, J.D.> ;Mol Cancer Ther. 2008 May
• Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
  Weisberg, E., Banerji, L., Wright, R.D., Barrett, R., Ray, A., Moreno, D., Catley, L., Jiang, J., Hall-Meyers, E., Sauveur-Michel, M., Stone, R., Galinsky, I., Fox, E....> ;Blood. 2008 Apr 1
• Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
  Weisberg, E., Kung, A.L., Wright, R.D., Moreno, D., Catley, L., Ray, A., Zawel, L., Tran, M., Cools, J., Gilliland, G., Mitsiades, C., McMillin, D.W., Jiang, J., Hall-...> ;Mol Cancer Ther. 2007 Jul
• Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
  Stegmaier, K., Wong, J.S., Ross, K.N., Chow, K.T., Peck, D., Wright, R.D., Lessnick, S.L., Kung, A.L., Golub, T.R.> ;PLoS Med. 2007 Apr
• Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.
  Weisberg, E., Catley, L., Wright, R.D., Moreno, D., Banerji, L., Ray, A., Manley, P.W., Mestan, J., Fabbro, D., Jiang, J., Hall-Meyers, E., Callahan, L., DellaGatta, J...> ;Blood. 2007 Mar 1
• Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.
  Weisberg, E., Wright, R.D., Jiang, J., Ray, A., Moreno, D., Manley, P.W., Fabbro, D., Hall-Meyers, E., Catley, L., Podar, K., Kung, A.L., Griffin, J.D.> ;Gastroenterology. 2006 Dec
• A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.
  Becker, C.M., Wright, R.D., Satchi-Fainaro, R., Funakoshi, T., Folkman, J., Kung, A.L., D'Amato, R.J.> ;Am J Pathol. 2006 Jun
• Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis.
  Almog, N., Henke, V., Flores, L., Hlatky, L., Kung, A.L., Wright, R.D., Berger, R., Hutchinson, L., Naumov, G.N., Bender, E., Akslen, L.A., Achilles, E., Folkman, J.> ;FASEB J. 2006 May
• Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.
  Weisberg, E., Manley, P.W., Breitenstein, W., Brüggen, J., Cowan-Jacob, S.W., Ray, A., Huntly, B., Fabbro, D., Fendrich, G., Hall-Meyers, E., Kung, A.L., Mestan, ...> ;Cancer Cell. 2005 Feb
• Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.
  Walensky, L.D., Kung, A.L., Escher, I., Malia, T.J., Barbuto, S., Wright, R.D., Wagner, G., Verdine, G.L., Korsmeyer, S.J.> ;Science. 2004 Sep 3
• Join now to see all